Age at onset in genetic prion disease and the design of preventive clinical trials
Eric Vallabh Minikel(Broad Institute), Simon Mead(Broad Institute), Inga Zerr(German Center for Neurodegenerative Diseases), Claudia Ponto(Broad Institute), Nobuo Sanjo(Broad Institute), Ignazio Roiter(Broad Institute), Christiane Stehmann(Broad Institute), Tsuyoshi Hamaguchi(Broad Institute), Piero Parchi(Institute of Neurological Sciences), Miguel Calero(Broad Institute), Roberto Chiesa(Broad Institute), Tadashi Tsukamoto(Broad Institute), Steven Collins(The Royal Melbourne Hospital), Margaret C. Orseth(Broad Institute), Michael D. Geschwind(University of California, San Francisco), Jiri Safar(Case Western Reserve University), Yosikazu Nakamura, Janna Kenny(Broad Institute), Stéphane Haı̈k(Broad Institute), Tetsuyuki Kitamoto(Broad Institute), Jamie Fong(Broad Institute), Péter Hermann(Broad Institute), Sabina Capellari(University of Bologna), Sonia M. Vallabh(Broad Institute), Jean Laplanche(Broad Institute), Masahito Yamada(Kanazawa University), Ryusuke Ae(Jichi Medical University), Jesús de Pedro‐Cuesta(Broad Institute), Jean‐Philippe Brandel(Broad Institute), Tobias Knipper(Broad Institute), Hidehiro Mizusawa(Broad Institute), Leonel Tadao Takada(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo)
Cited by 111
Related Papers
Analysis of protein-coding genetic variation in 60,706 humans
|Nature|2016|10.3k
A clinical approach to diagnosis of autoimmune encephalitis
|The Lancet Neurology|2016|4.4k
The mutational constraint spectrum quantified from variation in 141,456 humans
|bioRxiv (Cold Spring Harbor Laboratory)|2019|1.8k
Primary age-related tauopathy (PART): a common pathology associated with human aging
|Acta Neuropathologica|2014|1.5k